dabigatran has been researched along with Breast Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, F; Kidron, H; Neuvonen, M; Niemi, M; Santo, M; Sjöstedt, N | 1 |
| Anliker-Ort, M; Dingemanse, J; Janů, L; Kaufmann, P | 1 |
| Bazan-Socha, S; Dropiński, J; Pacholczak-Madej, R; Undas, A; Zaręba, L | 1 |
| Buijs, JT; Crooijmans, JJ; Kroone, C; Laghmani, EH; Le Dévédec, SE; Tieken, C; van den Akker, RFP; van der Molen, KM; van der Pluijm, G; Versteeg, HH; Vletter, EM | 1 |
| Fabris, F; Goss, A; Prandoni, P; Sambado, L; Vianello, F | 1 |
| Chernick, M; DeFeo, K; Gilmour, SK; Hayes, C; Ryn, JV | 1 |
6 other study(ies) available for dabigatran and Breast Neoplasms
| Article | Year |
|---|---|
Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Breast Neoplasms; Dabigatran; Drug Interactions; Female; Humans; Neoplasm Proteins; Pharmaceutical Preparations; Vemurafenib | 2023 |
Effect of Daridorexant on the Pharmacokinetics of P-Glycoprotein Substrate Dabigatran Etexilate and Breast Cancer Resistance Protein Substrate Rosuvastatin in Healthy Subjects.
Topics: Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Benzimidazoles; Breast Neoplasms; Dabigatran; Healthy Volunteers; Humans; Male; Neoplasm Proteins; Pyridines; Rosuvastatin Calcium | 2023 |
Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Breast Neoplasms; Cohort Studies; Dabigatran; Female; Humans; Middle Aged; Prospective Studies; Pyridones; Rivaroxaban; Stroke | 2021 |
The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice.
Topics: Animals; Anticoagulants; Antithrombins; Breast Neoplasms; Cell Line, Tumor; Dabigatran; Disease Progression; Factor Xa Inhibitors; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Rivaroxaban; Triple Negative Breast Neoplasms; Venous Thromboembolism; Xenograft Model Antitumor Assays | 2019 |
Dabigatran antagonizes growth, cell-cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines.
Topics: Antithrombins; Brain Neoplasms; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Dabigatran; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Poly (ADP-Ribose) Polymerase-1; Thrombin | 2016 |
Use of dabigatran etexilate to reduce breast cancer progression.
Topics: Animals; Antithrombin Proteins; Benzimidazoles; Breast Neoplasms; Cell Adhesion; Cell Movement; Cells, Cultured; Dabigatran; Disease Progression; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NIH 3T3 Cells; Pyridines; Rats; Thrombin; Trachea | 2010 |